by admin | Apr 28, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions,...
by admin | Apr 27, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
ALACHUA, Fla. (PRWEB)April 21, 2021 – Cardiovascular disease kills more than 650,000 Americans annually.(1) Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found...
by admin | Apr 23, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research Link to article The U.S. Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Products such as...
by admin | Apr 20, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Durham, NC – A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at...
by admin | Apr 19, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...
